Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Indonesia

 

FREE BLOG Standout themes from HBI’s Asia report

We’re about to release a Special Report on healthcare investment in Asia. The report offers a comprehensive overview of the dynamics, trends and opportunities in the healthcare markets of eight hugely important countries in the region: China, India, South Korea, Thailand, Vietnam, Indonesia, Malaysia and the Philippines. 

WhiteCoat acquires Good Doctor, creating Southeast Asia’s “largest digital healthcare group”

Singapore-based digital healthcare group WhiteCoat Global is acquiring Good Doctor Indonesia, a telemedicine platform with the largest insurer and corporate client network in Indonesia. WhiteCoat, which connects patients with payers and providers to deliver primary, specialist, and allied care, said in a statement the ‘landmark deal will create the region’s largest and most comprehensive digital healthcare group’. Thalia Georgiou, Managing Partner, Healthcare Advisory at Asia Care Group, also offers her perspective on the deal.

CVC Capital acquires major stake in Indonesia’s Siloam Hospitals, signalling rising PE interest in Southeast Asia healthcare

CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.

Far East Drug Co. acquires majority stake in Singapore’s Fullerton Health

Fullerton Health Corporation Limited (Fullerton Health), a multinational occupational health care provider in the Asia-Pacific region, confirmed on Tuesday that pharmaceutical company Far East Drug (B.V.I.) Co. Ltd (FED) is acquiring a significant stake in the Singapore-headquartered group.

Quadria investing $1.5bn into South and SE Asia

Singapore-based private equity firm Quadria Capital is set to inject $1.5bn worth of healthcare investments into South and South East Asian countries over the next two to three years. In line with growing trends, India stands to win big, earmarked to receive roughly 50% of the investment.

Ramsay Sime Darby sold to Columbia Asia for US$1.3bn

Multinational Asian hospital chain Columbia Asia is buying Ramsay Sime Darby, a rival SE Asian hospital chain, for US$1.3bn. This marks Australian hospital group Ramsay's exit from SE Asia, as well as Malaysian trading and logistics company Sime Darby Berhad's exit from health care.

Two bidders left for Ramsay Sime Darby, as CVC buys Filipino hospital chain

South East Asia is continuing to see much more large-scale M&A activity than Europe. The sale of Malaysian and Indonesian hospital group Ramsay Sime Darby is reaching its final stages, with only two bidders reportedly left in the running. Meanwhile, Luxembourg-based PE firm CVC Capital Partners has bought a controlling stake in The Medical City (TMC), the Philippines' most expansive hospital group in terms of outpatient clinic footprint.

Ramsay Sime Darby sale shortlist – Santé might be next

The sale of Malaysia and Indonesia-based hospital group Ramsay Sime Darby marches on, with a shortlist of candidates reportedly jostling for the $1.5bn purchase. Reports suggest French hospital group Ramsay Santé is next.

IHH makes two acquisitions but reports 51% drop in Q2 profit

Listed pan-Asian hospital giant IHH is continuing to grow through bolt-ons, having made two major acquisitions this month. For Q2 2023 the company reported a drop of 51% in net profit compared to Q2 2022, to RM302m ($65m). However, the company said this was mainly because the Q2 2022 figure was unusually high, and is continuing to grow organically as well as through M&A.

Find Us